IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

TRV GP III, LLC

Q3 2019 Holdings

Filed 2019-11-04 | 4 holdings | $176.5K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Voyager Therapeutics, Inc.(VYGR)COM92915B106$110.0K6,391,17662.3%
Fulcrum Therapeutics, Inc.(FULC)COM359616109$39.6K5,962,20222.4%
Neon Therapeutics, Inc.COM64050Y100$16.8K9,741,6369.5%
Jounce Therapeutics, Inc.(JNCEEUR)COM481116101$10.2K3,048,7805.8%